Associations between dialysis modality and adherence to immunosuppression after kidney transplantation-A single-center study.

Publication date: Jan 24, 2025

Patients with end-stage kidney disease often prefer home-based dialysis due to higher self-efficacy, which relates to improved medical treatment adherence. Kidney transplantation (KT) success depends on adhering to immunosuppressive medication post-transplant. To investigate whether adherence post-kidney transplantation (KT) and patients’ attitudes toward immunosuppression were influenced by their prior dialysis type modality. Additionally, the study examined if adherence and patient’s attitudes towards immunosuppression are associated with kidney graft survival. This cross-sectional single-center study included 201 KT patients. Adherence was assessed using BAASIS and the coefficient of variation of calcineurin inhibitors (COV-CNI). Patient attitudes towards medication were evaluated using the Q-method. Pill burden, comorbidity score and HRQoL and medication complexity, were scored. Cox regression was applied to determine KT survival outcomes over a 14-year follow-up period (until Dec 2021). Prior dialysis modality was not associated with adherence to immunosuppression post-KT evaluated by BAASIS on average 4. 7 years post-KT. Previous in-center hemodialysis patients had a higher CNI-COV (p = 0. 011). The Q-sort analysis identified fully adherent patients linked to profile 1 (organized, resilient) whereas profile 2 patients were more careless. Patients linked to profile 3 (challenging, nervous) had higher education, a higher pill burden, and experienced more immunosuppression side effects. Death-censored graft loss increased by 7. 6% with each additional pill, quadrupled if one dose of immunosuppression was missed, and increased by 2. 9% for each point of COV-CNI rise. Adherence to immunosuppression post-KT using BAASIS was not associated with prior dialysis type, despite in-center hemodialysis patients showing the highest COV-CNI. Taking COV-CNI into account, managing missed doses of immunosuppressants, and exploring patient attitudes could potentially enhance adherence and consequently improve KT survival.

Open Access PDF

Concepts Keywords
Education Adult
Hemodialysis Aged
Kidney Cross-Sectional Studies
Nervous Female
Graft Survival
Humans
Immunosuppression Therapy
Immunosuppressive Agents
Immunosuppressive Agents
Kidney Failure, Chronic
Kidney Transplantation
Male
Medication Adherence
Middle Aged
Renal Dialysis

Semantics

Type Source Name
disease IDO immunosuppression
disease MESH end-stage kidney disease
drug DRUGBANK Spinosad
disease MESH comorbidity
disease MESH Death
pathway REACTOME Reproduction
drug DRUGBANK Trestolone
disease MESH lifestyle
disease MESH chronic diseases
disease IDO blood

Original Article

(Visited 1 times, 1 visits today)